Analyst Reports

Cannabis Boom Or Bust: State Trends Marijuana Investors Can't Afford To Ignore In 2Q24
Is Tilray Really Worth $2B? Analysts Sees Path To $10B Market Opportunity
Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%
Is Tilray Really Worth $2B? Analysts Sees Path To $10B Market Opportunity
Cannabis Rescheduling Signals Strong Returns, Tax Breaks Could Increase This Stock's Market Cap By 170%
How To Max Profits This 4/20, Smart Discounts Amid Sales Spike Of Premium Marijuana
A Top Weed Stock Under The Radar: Strong Growth, Cash Flow Savings And Low-Value Market Position

Analyst Reports Recent News

What's Going On With Cannabis Pricing In Illinois? Analyst Examines Retailers' Menus
Illinois is one of the most prominent cannabis markets in the U.S. In 2022, recreational marijuana sales crossed the $1 billion mark.
Is Fire & Flower Joining 'The Discount Parade'? New Strategy Boosts Retail Cannabis Sales
The Analyst 
Want Exposure To The Canadian Recreational Cannabis Market? These Are The 3 Best Picks, According To A Cantor Analyst
In a recent analyst note, Pablo Zuanic from Cantor Fitzgerald offered an update on the performance of Canada’s cannabis Licensed Producers in the August quarter, based on data obtained by the market scanner Hifyre.
Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And… A Costly Preferred Stock Raise?
On Thursday, analyst Pablo Zuanic from Cantor Fitzgerald offered an industry update on four recent M&A deals and Glasshouse Series B Preferred stock issuance.
Cantor's Top Picks: Could Q2 Earnings Provide A Spark For These Cannabis Multi-State Operators?
Multi-State Operators (MSO) traded higher on Tuesday after Cantor Fitzgerald categorized four companies as "top picks." In a recent industry report, Pablo Zuanic analyzed the context of MSOs and offered insight on trends driving financial value. Although MSOs ETF fell 25% in June and 49% over the last three months (vs.
Why Morgan Stanley Says Second Quarter Earnings Are Critical, And Earnings Revisions Are Inevitable
With the second quarter coming to an end for the U.S. economy, there has been a noticeable decrease in interest rates, as the ten-year treasury yield fell to 2.833% on Tuesday.
Analyst: Updating Tilray's Numbers Ahead Of Aug Qtr Print
Cantor Fitzgerald analyst Pablo Zuanic shared an update on Tilray's (NASDAQ: TLRY) Aug qtr sales estimates in his Thursday note.
UBS Analyst Upgrades Target: What You Need To Know
UBS analyst Michael Lasser upgraded Target Corporation (NYSE: TGT) stock from Neutral and raised its price target from $210 to $265.
Cantor Analyst Raises Aphria And Tilray Price Targets Amid Merger
Cantor Fitzgerald analyst Pablo Zuanic expressed disappointment by Aphria Inc. (TSX: APHA) (NASDAQ: APHA) quarterly results in an analyst note published Friday.
Was The House Vote On The MORE Act A Strategic Mistake? A Cantor Analyst Weighs In
On Friday, the House of Representatives voted 228 to 164 in favor of the Marijuana Opportunity Reinvestment and Expungement (MORE) Act.
Morgan Keegan Says Sun Healthcare (SUNH) to Outperform

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga

© 2024 Benzinga | All Rights Reserved